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ABSTRACT
Molecular therapy, including gene therapy, is a promising strategy for the treatment of human disease. How-
ever, delivery of molecular therapeutics efficiently and specifically to the target tissue remains a significant
challenge. A human transferrin (Tf)-targeted cationic liposome–DNA complex, Tf–lipoplex, has shown high
gene transfer efficiency and efficacy with human head and neck cancer in vitro and in vivo (Xu, L., Pirollo,
K.F., Tang, W.H., Rait, A., and Chang, E.H. Hum. Gene Ther. 1999;10:2941–2952). Here we explore the struc-
ture, size, formation process, and structure–function relationships of Tf–lipoplex. We have observed Tf–lipoplex
to have a highly compact structure, with a relatively uniform size of 50–90 nm. This nanostructure is novel in
that it resembles a virus particle with a dense core enveloped by a membrane coated with Tf molecules spik-
ing the surface. More importantly, compared with unliganded lipoplex, Tf–lipoplex shows enhanced stability,
improved in vivo gene transfer efficiency, and long-term efficacy for systemic p53 gene therapy of human
prostate cancer when used in combination with conventional radiotherapy. On the basis of our observations,
we propose a multistep self-assembly process and Tf-facilitated DNA cocondensation model that may provide
an explanation for the resultant small size and effectiveness of our nanostructural Tf–lipoplex system.
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OVERVIEW SUMMARY
Our Tf–lipoplex system shows enhanced stability, improved
in vivo gene transfer efficiency, and long-term efficacy for
systemic p53 gene therapy of human prostate cancer when
used in combination with conventional radiotherapy. We
have found Tf–lipoplex molecules to have a highly compact
structure with a relatively uniform size of 50–90 nm. This
novel nanostructure resembles the structure of a virus par-
ticle with a dense core enveloped by a membrane coated
with Tf molecules spiking the surface. A multistep self-as-
sembly process and Tf-facilitated DNA cocondensation
model is proposed on the basis of our observations and likely
contributes to the small size and effectiveness of the
Tf–lipoplex nanostructure.
INTRODUCTION
MOLECULAR THERAPY, including gene therapy, is a promis-ing strategy for the treatment of human disease. How-
ever, delivery of molecular therapeutics efficiently and specif-
ically to the target tissue remains a significant challenge (Mar-
shall et al., 2000). Progress has been made toward developing
nonviral, pharmaceutical formulations of genes for in vivo hu-
man therapy, particularly cationic liposome-mediated gene
transfer systems (Pirollo et al., 2000). However, these cationic
liposome–DNA complexes (lipoplexes) suffer from low gene
transfer efficiency, large particle size, poor stability, and, more
importantly, lack of targeting capability (Pirollo et al., 2000).
Current efforts at tumor targeting of lipoplexes for targeted gene
delivery and systemic gene therapy directed by inclusion of a
ligand in the complex are encouraging (L. Xu et al., 2001). To
improve the gene transfer efficiency and tumor targetability of
lipoplexes, we incorporated human transferrin (Tf) into the
complex to form Tf–lipoplex (L. Xu et al., 1997, 1999a).
Tf–lipoplex has demonstrated high efficiency in tumor-targeted
gene delivery and long-term therapeutic efficacy in systemic
p53 gene therapy for both human head and neck cancer (L. Xu
et al., 1999a) and prostate cancer (see below).
There has been an increasing number of publications on the
structure of cationic liposome–DNA complexes or lipoplexes
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(Battersby et al., 1998; Dan, 1998; Sternberg et al., 1998; Hueb-
ner et al., 1999; Kennedy et al., 2000; Lin et al., 2000). Sev-
eral models have been proposed, largely on the basis of elec-
tron microscopy (EM), small-angle X-ray scattering (SAXS),
and atomic force microscopy (AFM) studies (Radler et al.,
1997; Dan, 1998; Kawaura et al., 1998; Koltover et al., 1999;
Kennedy et al., 2000). A widely cited model in the literature is
the lamellar LaC structure, in which the DNA helix is sand-
wiched between cationic lipid bilayers in ordered two-dimen-
sional arrays (Lasic et al., 1997; Radler et al., 1997; Koltover
et al., 1998; Lin et al., 2000). However, the structure and for-
mation process of the much more efficient and efficacious
Tf–lipoplex has yet to be elucidated. Using cryoelectron mi-
croscopy (cryo-EM), negative-staining EM, and photon corre-
lation spectroscopy, we have observed a highly compact struc-
ture of Tf–lipoplex with a relatively uniform size of 50–90 nm.
This nanostructure is novel in that its structure resembles that
of a virus particle (e.g., influenzavirus or herpesvirus) with a
dense core enveloped by a membrane coated with Tf molecules
spiking the surface. Here we attempt to elucidate the mecha-
nism by which the Tf-coated cationic liposomes could effi-
ciently condense DNA into this virus-mimicking nanostructure
and to understand how the Tf molecules are involved in the
self-assembly process of the Tf–lipoplex. On the basis of our
observations and the above-mentioned lipoplex structure mod-
els, we propose a multistep self-assembly process and Tf-fa-
cilitated DNA cocondensation model that may provide an ex-




Cationic liposomes (Lip) consisting of dioleoyl trimethyl-
ammonium propane (DOTAP) and dioleoyl phosphatidyl-
ethanolamine (DOPE) (Avanti Polar Lipids, Alabaster, AL) at
a 1:1 molar ratio were prepared either by sonication or ethanol
injection as previously described (L. Xu et al., 1997, 1999a,
2001). Tf–Lip–DNA was prepared according to the in vivo for-
mulation described previously (L. Xu et al., 1999a). Briefly, for
a typical preparation with optimized in vivo formulation, 25 ml
of Tf (5 mg/ml, iron-saturated holo-transferrin; Sigma, St.
Louis, MO) and 50 ml of Lip (2 mM total lipids) plus 75 ml of
water were mixed in a polypropylene tube and incubated for
5–15 min at room temperature with frequent rocking. Ten mi-
crograms of plasmid DNA in 120 ml of 20 mM HEPES buffer,
pH 7.4, was added to the tube, mixed immediately and thor-
oughly, and incubated for 20 min at room temperature with fre-
quent rocking. Thirty microliters of 50% dextrose solution was
then added to the tube. The final DNA:lipid:Tf ratio was
1:10:12.5 (mg/nmol/mg). The HEPES buffer can be replaced by
pure water.
In vitro transfection
For optimization of Tf–liposome–DNA complex preparation
and transfection conditions, the quantitative b-galactosidase
colorimetric assay was employed as described previously (L.
Xu et al., 1997, 1999a). DU145 cells (1 3 104) were plated in
each well of a 96-well plate. Twenty-four hours later, the cells
were washed once with Eagle’s minimal essential medium
(EMEM) without serum or antibiotics and 100 ml of transfec-
tion solution containing various amounts of Tf–liposome–
pCMVb as well as lipoplex without Tf was added to each well.
After 5 hr of transfection at 37°C, 100 ml of EMEM contain-
ing 20% fetal bovine serum was added to each well. Forty-eight
hours later, the cells were washed once with phosphate-buffered
saline (PBS) and lysed in 50 ml of 0.1 M Tris (pH 7.5) con-
taining 0.1% Triton X-100 and 1 mM MgCl2. The cell lysates
were treated with 100 ml of 150 mM o-nitrophenyl-b-D-galac-
topyranoside in 20 mM Tris (pH 7.5) containing 1 mM MgCl2
and 450 mM 2-mercaptoethanol at 37°C for 1 hr. The reaction
was stopped by the addition of 1 M Na2CO3 (150 ml/well). The
absorbance was determined at 405 nm. Purified b-galactosidase
(Boehringer, Indianapolis, IN) was used as standard. The re-
sults were expressed as milliunits (mU) of b-galactosidase
equivalent per milligram of total protein.
In vivo efficacy study
Xenograft tumors were induced by the subcutaneous injec-
tion of 6 3 106 DU145 cells in Matrigel basement membrane
matrix (Collaborative Biomedical Products, Bedford, MA) into
the lower back, above the tail, of 4- to 6-week-old female
athymic nude mice. Mice bearing tumors of , 70 to 100 mm3
were injected, via the tail vein, with Tf–Lip–p53 or Tf–Lip–pVec
at 10 mg of DNA per 0.3 ml per injection, twice weekly for a
total of 10 injections, and the tumors only were exposed to 2.0-
Gy fractionated doses of g radiation (total, 40 Gy) (L. Xu et al.,
1999a). For comparison, control groups included a group of un-
transfected mice with or without radiation, as well as a group of
mice with Tf–Lip–p53 injection receiving no radiation. Each ex-
perimental group consisted of five animals. The tumor sizes were
measured weekly in a blinded manner. All animal experiments
were performed in accordance with Georgetown University in-
stitutional guidelines for the care and use of animals.
Filtration of Tf–lipoplexes
Tf–lipoplex was prepared as described above, using DNA of
pCMVb, a plasmid carrying the Escherichia coli b-galactosi-
dase gene. Nontargeted lipoplex was prepared similarly but
without Tf. Tf–lipoplex and lipoplex were filtered serially
through polycarbonate membranes (Nuclepore, Pleasanton,
CA) starting with a pore size of 400 nm, followed by 200, 100,
80, and 50 nm. The membranes were mounted in 25-mm stain-
less steel filter holders (Millipore, Bedford, MA). After each
filtration, samples were collected and either the OD600 nm was
determined or the DNA concentration was measured to calcu-
late the percentages of each pass-through. To measure DNA
concentrations, a PicoGreen double-stranded DNA (dsDNA) kit
(Molecular Probes, Eugene, OR) was used with samples lysed
by 0.5% Triton X-100 (Sigma). In vitro transfection studies
were carried out as previously described (L. Xu et al., 1997,
1999a,b). For p53-mediated cytotoxicity studies, DU145 cells
in a 96-well culture plate were treated with serially filtered
Tf–Lip–p53, the same as in in vitro transfection. Forty-eight
hours after treatment, the XTT cytotoxicity assay was per-
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formed and the ED50, that is, the effective dose of DNA
(ng/well) that kills 50% of cells, was calculated (L. Xu et al.,
2001).
Photon correlation spectroscopy
The sizes and z potentials of Tf–liposomes and Tf–lipoplexes
were measured by photon correlation spectroscopy, also known
as dynamic light scattering (Y. Xu et al., 1999), using a Zeta-
sizer 3000HS (Malvern, Southboro, MA). The measurements
were performed according to the manufacturer instructions with
the following settings: temperature, 25°C; scattering angle, 90°;
analysis mode, CONTIN by number. The results are presented
as the mean 6 the standard deviation of at least three prepara-
tions; each preparation was measured three times.
Electron microscopy analysis of Tf–Lipoplex
Cryoelectron microscopy (cryo-EM) was performed as de-
scribed (Lasic et al., 1997; Templeton et al., 1997; Y. Xu et al.,
1999). Briefly, a grid was dipped in and withdrawn from a sam-
ple vial, blotted with filter paper, and by a guided drop vitrified
in melting ethane. Specimen preparation was done in a controlled
environment (temperature, humidity) with a fully automated (PC-
controlled) system. The vitrified specimens were transferred to a
cryoholder (operating at 2170°C) and observed in a Philips (Mt.
Vernon, NY) CM12 microscope at 120 kV under low-dose con-
ditions. Transmission electron microscopy with 4% uranium ac-
etate negative staining was carried out as described (Dan, 1998).
A JEOL (Akishima, Japan) 1200EX or JEOL 100S was used in
this study. The liposome samples on the grids were prepared,
freshly stained, and observed within 1 hr.
RESULTS
Optimization of Tf–Lipoplex
We have previously shown that the tumor suppressor gene
p53 delivered by Tf–lipoplex optimized for head and neck can-
cer could, in combination with conventional radiotherapy, re-
sult in long-term tumor regression in a xenograft tumor model
(L. Xu et al., 1999a). To optimize the Tf–lipoplex formulation
for gene delivery to human prostate cancer cells, a quantitative
b-galactosidase colorimetric assay (L. Xu et al., 1999a) was
employed. Human prostate cancer cell line DU145 was used as
a model. The tumor cells were transfected with Tf–lipoplex pre-
pared at various DNA:lipid:Tf ratios, using a plasmid contain-
ing the E. coli b-galactosidase gene as the reporter gene
(pCMVb), as previously described for the in vivo formulation
(L. Xu et al., 1997, 1999a). Figure 1a shows that transferrin
significantly enhanced the transfection efficiency of cationic li-
posomes. Interestingly, the optimal formulation for prostate
cancer cells has a DNA:lipid:Tf ratio of 1 mg:10 nmol:12.5mg,
the same as that optimized for the human head and neck can-
cer model (L. Xu et al., 1999a). For prostate cancer cell line
DU145, the transfection efficiency is comparable to that of the
head and neck cancer cell line JSQ-3, with an in vitro efficiency
of 60–70% and in vivo efficiency of 20–30%, as we have re-
ported previously (L. Xu et al., 1997, 1999a). This optimized
Tf–lipoplex is quite stable. Storage under nitrogen at 4°C for 1
month did not result in any significant loss of in vitro trans-
fection activity (Fig. 1b).
Tf–Lipoplex-mediated systemic gene delivery to 
human prostate cancer xenografts
To evaluate in vivo tumor-targeted gene delivery, plasmid
pGFP, containing a reporter gene encoding green fluorescent
protein, was complexed in Tf–lipoplex, nontargeted lipoplex
(no targeting ligand), or bovine serum albumin (BSA)-com-
plexed lipoplex (BSA–lipoplex). BSA has a similar, although
slightly lower molecular mass (69 kDa) than Tf (77 kDa) and
was used here as a negative control to demonstrate ligand-spe-
cific targeting. The complexes were injected via the tail vein
(32 mg of DNA per 0.6 ml, three injections within 24 hr) into
nude mice bearing DU145 subcutaneous xenografts. Forty-eight
hours after the first injection, the tumors and major organs were
excised for Western analysis of GFP expression as previously
described (L. Xu et al., 1999a,b). As shown in Fig. 2a, the tu-
mor in the Tf–lipoplex-injected mouse showed significant ex-
pression of the GFP gene whereas no expression was observed
in the tumors of the animals injected with lipoplex or
BSA–lipoplex. The Tf–lipoplex-mediated systemic gene deliv-
ery was tumor specific in that the liver and lung showed no ob-
vious gene expression (Fig. 2a). The same was true for other
normal tissues and organs (data not shown). Using histochem-
ical staining in a study of head and neck cancer xenograft tu-
mors treated with Tf–lipoplex, we have previously shown that
expression of the b-galactosidase reporter gene was evident
only in the tumor cells, whereas normal organs showed only
staining of the macrophages (L. Xu et al., 1999a).
To assess Tf–lipoplex-mediated p53 gene delivery and ex-
pression, nude mice bearing DU145 subcutaneous tumors
were injected with Tf–Lip–p53 via the tail vein (20 mg per
0.6 ml, four injections within 32 hr). The tumors and major
organs were excised 48 hr after the first injection for West-
ern analysis of exogenous p53 gene expression as previously
described (L. Xu et al., 1999a,b). As shown in Fig. 2b, the tu-
mor in the Tf–Lip–p53-injected mouse showed a high level of
exogenous wild-type p53 expression. In contrast, no significant
exogenous p53 expression was found in tumors from the mouse
injected with nontargeted Lip–p53. Consistent with the GFP
study, intravenous injection of Tf–Lip–p53 led to only limited
exogenous p53 expression in liver, lung, and spleen (Fig. 2b).
Our previous study (L. Xu et al., 1999a) has shown that only
macrophages such as histiocytes of the lung or the Kupffer cells
of the liver of the animals intravenously injected with
Tf–lipoplex showed transgene expression, whereas the lung
alveolar cells and the hepatocytes remained negative. Both GFP
and p53 experiments were repeated at least three times with
representative results shown in Fig. 2a and b.
Efficacy of systemic p53 gene therapy in human
prostate cancer animal model
To determine the in vivo efficacy of Tf–lipoplex-mediated
p53 gene therapy, the DU145 subcutaneous xenograft tumor
model was also employed (L. Xu et al., 1999b). Nude mice
bearing tumors of 70 to 100 mm3, equivalent to an , 1-lb tu-
mor in a 200-lb person, were injected, via the tail vein, with
Tf–Lip–p53, Tf–Lip–pVec (plasmid vector without p53), or
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nontargeted Lip–p53, at 10 mg of DNA per 0.3 ml per injec-
tion, twice weekly for a total of 10 injections. The tumor area
only was exposed to 2.0-Gy fractionated doses of g radiation
(total, 40 Gy), as previously described (L. Xu et al., 1999a). As
shown in Fig. 3, Tf–lipoplex showed improved efficacy in sys-
temic p53 gene therapy of human prostate cancer as compared
with untargeted Lip–p53. More significantly, when combined
with radiation, the Tf–Lip–p53-treated group exhibited com-
plete tumor regression and showed no signs of recurrence 6
months after treatment (p , 0.001, Student’s t test). This is con-
sistent with an earlier report of the long-term efficacy of
Tf–Lip–p53 radiosensitization in a head and neck cancer ani-
mal model (L. Xu et al., 1999a).
Tf–Lipoplex particle size–function relationship
To understand why the inclusion of Tf in the lipoplex parti-
cles results in such a profound effect on tumor-targeted gene
delivery efficiency and efficacy, we performed studies to char-
acterize this optimized in vivo Tf–lipoplex formulation. First,
to examine the effect of Tf–lipoplex particle size on gene trans-
fection efficiency and p53-mediated tumor cell killing,
Tf–lipoplex, as well as nontargeted lipoplex, were serially fil-
tered through polycarbonate membranes with pore sizes of 400,
200, 100, 80, and 50 nm. After each filtration, the percentage
of each pass-through was determined either by DNA concen-
tration or OD600 nm (see Materials and Methods). As shown in
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FIG. 1. Optimization of Tf–lipoplex formulation for human prostate cancer cell line DU145. (a) Human prostate cancer DU145
cells were transfected with Tf–lipoplex containing pCMVb at various DNA:lipid:Tf ratios, as previously described (L. Xu et al.,
1997, 1999a). The optimized formulation for DU145 cells is a DNA:lipid:Tf ratio of 1 mg:10 nmol:12.5 mg. (b) Stability of the
optimized Tf–lipoplex formulation. Tf–lipoplex preparations were stored under nitrogen at 4°C for various time periods and as-
sayed for DU145 transfection as in (a). Tf–lipoplex with the optimal formulation is stable for up to 1 month in vitro.
Fig. 4a, 80% of particles in the optimal Tf–lipoplex formula-
tion easily passed through the 100-nm pore size filter, 70%
passed through the 80-nm pore size filter, and 60% passed
through the 50-nm pore size filter. The OD600 nm showed re-
sults comparable to the DNA concentration results (data not
shown). However, lipoplex without Tf could pass through the
100-nm pore size filter only after applying much greater pres-
sure. This is consistent with lipoplex sizes of 150–400 nm as
reported by other groups (Huebner et al., 1999; Lin et al., 2000).
Although transfection efficiency for all particle sizes is DNA
dose dependent, in in vitro transfection using pCMVb as the
reporter gene (Fig. 4b), at a DNA dose of 0.05 mg/well, the 50-
nm pore size-filtered Tf–lipoplex showed a 3-fold higher trans-
fection activity than the nonfiltered Tf–lipoplex. The order of
transfection efficiency from these data was found to be as fol-
lows: 50-nm filtered . 80-nm filtered . 100-nm filtered .
nonfiltered. A similar order was also observed in Tf–lipoplex-
directed, tumor suppressor gene p53-mediated tumor cell killing
that was measured as the ED50, the effective dose of DNA
(ng/well) that kills 50% of cells. The Tf–Lip–p53 ED50 order
was found to be as follows: 50-nm filtered 5 80-nm filtered
(ED50 5 25 ng) . 100-nm filtered (64 ng) . 200-nm filtered
(66 ng) . 400-nm filtered (82.5 ng) . nonfiltered (112.5 ng).
On the basis of the ED50, the 50- to 80-nm pore size-filtered
particles are significantly more effective than the nonfiltered
particles. These results demonstrate that the smaller sized par-
ticles have better biological activity. Approximately 80% of the
particles are smaller than 100 nm. Consequently, to facilitate
sample preparation, the Tf–lipoplex particles used in in vivo
studies were not filtered.
We further measured the particle size and z potential of the
Tf–lipoplex particles by dynamic laser light scattering (DLS;
Y. Xu et al., 1999). The cationic liposome (Lip) itself has a di-
ameter of 28.7 6 5.1 nm (mean 6 SD, n 5 7 batches) and a 
net positive charge of 161.7 6 3.5 mV (n 5 11). Lip–DNA
lipoplex has a size of 150–350 nm and z potential of 130–35
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FIG. 2. In vivo systemic gene delivery and expression by optimized Tf–lipoplex. (a) Tumor-targeted delivery of GFP gene.
Lipoplex, Tf–lipoplex, or BSA–lipoplex was injected via the tail vein (three injections of 32 mg of DNA within 24 hr) into nude
mice bearing human prostate cancer DU145 subcutaneous xenografts. Forty-eight hours after the first injection, the tumors and
major organs were excised for Western analysis of GFP expression. A total of 80 mg of protein was loaded per lane and an anti-
GFP monoclonal antibody (BAbCO, Berkeley, CA) was used for Western analysis. We observed that actin and GAPDH were
expressed at different levels between human tumor xenografts and mouse organs. Therefore, to demonstrate that the same amount
of protein was loaded in each lane, a Ponceau S kit (Sigma) was employed to stain the membrane. The tumor in the Tf–lipoplex-
injected mouse showed significant GFP expression whereas no expression was observed in tumors in the animals injected with
lipoplex or BSA–lipoplex. 1CTL, Positive control, DU145 cells transfected with Tf–Lip–pGFP. (b) Systemic p53 gene delivery
and expression, as described in Materials and Methods. A total of 80 mg of protein was loaded per lane. The mouse intravenously
injected with Tf–Lip–p53 (four injections of 20 mg within 32 hr) showed high-level exogenous wild-type p53 expression in tu-
mor whereas only limited expression occurred in mouse organs including liver, lung, and spleen. 1CTL, Positive control, DU145
cells transfected with Tf–Lip–p53.
mV. Tf-coated liposome, Tf–Lip, has a size of 30.6 6 4.8 nm
and a net positive charge of 145.3 6 1.3 mV. When complexed
with plasmid DNA, the size of Tf–lipoplex particles is 63.8 6
6.3 nm, with a close to neutral surface charge (z potential,
12.3 6 1.9 mV; n 5 14). The DLS results confirmed that the
vast majority of Tf–lipoplex particles are between 50 and 90
nm in diameter. It is worth noting that 50-nm pore size-filtered
Tf–lipoplex has a diameter of 60–65 nm as determined by DLS,
indicating that Tf–lipoplex has a certain degree of flexibility
permitting it to pass through the 50-nm pore size filter.
These results indicate that these small (50- to 90-nm) parti-
cles are likely to be the population accounting for the high ef-
ficiency and efficacy of Tf–lipoplex-mediated gene delivery.
This particle size range is consistent with studies of tumor mi-
crovasculature showing that small particles effectively pass
through blood vessels via transendothelial cell pores ,100 nm
in diameter (Feng et al., 1997). The results also imply that one
of the consequences of including Tf in Tf–lipoplex is the de-
crease in particle size and thus improved efficiency.
Ultrastructure of Tf–Lipoplex
How can we account for the apparent decrease in size and
increase in efficiency of lipoplex when it contains Tf? Using
125I-labeled Tf and Sepharose-4B chromatography, it has been
previously demonstrated (Cheng, 1996) that Tf can associate
with cationic liposomes, presumably through electrostatic in-
teraction. When mixed, negatively charged Tf will bind to
cationic liposomes, coating the surface of the liposomes. To 
attempt to elucidate structural changes associated with the 
formation of Tf–lipoplex, we examined the ultrastructure of
Tf–lipoplex by cryoelectron microscopy (Gustafsson et al.,
1995; Templeton et al., 1997). DOTAP:DOPE liposomes are
typical small (20- to 30-nm) unilamellar vesicles (SUVs; see
Fig. 5a). When mixed with Tf, a 2- to 3-nm layer of Tf coat-
ing can be seen protruding from the bilayer surface (Fig. 5b and
insets). After complexing with plasmid DNA according to the
optimized in vivo formulation, the resulting Tf–lipoplex showed
a uniformly condensed core structure surrounded by a Tf-coated
membrane. The Tf–lipoplex particles have a diameter of 50–90
nm, with the majority being approximately 60–75 nm in diam-
eter (Fig. 5c–h). Tf–lipoplex was found to be of similar struc-
ture and size irrespective of the method of SUV preparation,
that is, by sonication (Fig. 5c–e) or by ethanol injection (Fig.
5f–h). High-magnification images of the Tf–lipoplex in Fig. 5d
and Fig. 5g1 and g2 (enlarged from Fig. 5g) show a condensed
core structure surrounded by a membrane coated with Tf spikes
on the surface. Two types of particles were observed by cryo-
EM: light particles with a bright center (Fig. 5c–e) and dark
particles with a high electron density center (Fig. 5c and g).
The dark particles dominate the Tf–lipoplex population (more
than 80–90%; Fig. 5c, g, and h). We do not as yet understand
the reasons behind, or the differences between, these two types
of particles. Close examination of the dark particles indicates
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FIG. 3. Effect of the combination of Tf–Lip–p53 and radiation treatment on DU145 xenografts in vivo. Nude mice bearing tu-
mors of , 70 to 100 mm3 were injected, via the tail vein, with Tf–Lip–p53, Tf–Lip–pVec (plasmid vector without p53), or non-
targeted Lip–p53, 10 mg of DNA per 0.3 ml per injection, twice weekly for a total of 10 injections, and the tumors only were
exposed to 2.0-Gy fractionated doses of g radiation (total, 40 Gy), as previously described (L. Xu et al., 1999a). There were five
nude mice per group. The horizontal bar indicates the duration of treatment. The standard error for the combination group was
negligible. The Tf–Lip–p53 plus radiation-treated group exhibited complete tumor regression and showed no signs of recurrence
even 6 months after treatment.
that their structure closely resembles that of a coated virus par-
ticle, for example, influenzavirus or herpesvirus. This is the first
report demonstrating a self-assembled, ligand-targeted, nonvi-
ral vector that closely resembles a virus particle both in archi-
tecture and in its uniformly small size. This virus-like compact
nanostructure may be the key to their high gene transfer effi-
ciency and efficacy both in vitro and in vivo.
To further analyze the arrangement of the dense core struc-
ture of Tf–lipoplex, electron microscopy with negative staining
was employed (Perevucnik et al., 1985; Tranum-Jensen, 1988).
As shown in Fig. 6, the center of the Tf–lipoplex particle con-
sists of a highly compact, multicentered, ordered onion-like
structure, which we call a multicenter lamellar core structure.
This lamellar core structure has a periodicity of 6–7 nm (Fig.
6d–i). The formation of the Tf–lipoplex particles is quick and
efficient (occurring within several minutes) (L. Xu et al.,
1999a). The Tf–lipoplex particles are a homogeneous popula-
tion of small size (50–90 nm) (Fig. 6d–g), whereas the lipoplex
particles without Tf are heterogeneous and much larger, with a
greater size range of 100–300 nm (Fig. 6j). Interestingly, all
Tf–lipoplex particles showed similar lamellar core structures on
EM observation of negatively stained specimens. This is in con-
trast to the two populations, light and dark particles, found by
cryo-EM, implying that both light and dark particles have the
same structure and possibly have the same biological activity.
The Tf–lipoplexes containing different sizes of plasmid DNA
(e.g., pVec, 4.5 kbp; pCMVp53, 6.2 kbp; pCMVb, 7.9 kbp)
showed similar size, z potential, and nanostructure. Therefore,
at least in the range of 4 to 8 kbp, the size of DNA encapsu-
lated is apparently not critical.
Self-assembly process of Tf–Lipoplex
In an attempt to elucidate the Tf–lipoplex formation process,
we mixed Tf–liposome with DNA for 5–20 sec, instead of the
usual 15 min, before applying the sample to the grid for EM.
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FIG. 4. Effects of Tf–lipoplex particle size on gene transfection efficiency. (a) The percentage of Tf–lipoplex that passes through
serial filters, on the basis of DNA concentration, as described in Materials and Methods. The majority of the Tf–lipoplex can
pass through the 50- to 80-nm pore size filter. (b) Effect of particle size on transfection activities. DU145 cells in a 96-well plate
were transfected with serially filtered Tf–lipoplex containing pCMVb, as described previously (L. Xu et al., 1997, 1999a). Small
particles (50-nm pore size filtration) are more efficient than nonfiltered particles, which consist of both small and large particles.
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FIG. 5. Cryo-EM analysis of Tf–lipoplex particles. (a) Cationic liposomes (DOTAP:DOPE, 1:1 molar ratio) prepared by the
ethanol injection method (L. Xu et al., 2001). (b) Tf-coated liposomes (Tf–Lip). A 2- to 3-nm layer of Tf coating can be seen
protruding from the bilayer surface (insets). The size of the liposomes does not significantly change after Tf coating. (c–h) Im-
ages of Tf–lipoplex particles prepared from SUVs made either by sonication (c–e) or by ethanol injection (f–h), according to the
optimized in vivo formulation. (d and e) Higher magnification images of (c) with strong defocus to improve the contrast of Tf
spikes. (g1 and g2) Higher magnification images of (g). Tf–lipoplex particles are 50–90 nm in diameter. Tf–lipoplex has a uni-
formly condensed core structure surrounded by a Tf-coated membrane, resembling a virus particle. Both dark and light particles
can be seen in the preparation. Dark particles are the dominating population. Magnification bars: 100 nm.
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FIG. 6. Negative-stain EM analysis of Tf–lipoplex. (a) Cationic liposomes; (b) Tf–liposome (no DNA); (c) Tf–lipoplex; (d–i)
higher magnification images of Tf–lipoplex; (j) lipoplex without Tf. The center of the Tf–lipoplex particle consists of a highly
compact, multicentered, ordered onion-like structure, which we call a multicentered lamellar core structure. The lamellar core
structure has a periodicity of 6–7 nm. The Tf–lipoplex particles are a homogeneous population of 50–90 nm, whereas the lipoplex
particles have a greater size range of 100–300 nm. Magnification bars: 100 nm.
In this way, we observed various steps in complex formation, for
example, the stepwise condensation of the DNA chain by Tf–Lip
(Fig. 7a). All of these intermediate stages existed simultaneously.
Analysis of a large number of images from negatively stained
specimens, including those representative of intermediate stages
of Tf–lipoplex formation, supplemented by cryo-EM observa-
tions, led us to postulate that this multicenter lamellar core struc-
ture is formed in a three-step process during the formation of
Tf–lipoplex. These steps are shown in both representative EM
images (Fig. 7a) and schematic illustration (Fig. 7b).
Step 1: Several (four to eight or more) Tf–liposome (Tf–Lip)
particles come into contact with a DNA molecule, attaching
to the DNA strand by electrostatic interaction.
Step 2: The attached Tf–liposome particles condense the DNA
to form individual lamellar structures along the DNA strand.
Step 3: The individual lamellar structures condense or fuse to
form one larger unit: an ordered and highly compact, onion-
like structure, designated as the condensed lamellar core struc-
ture. This core is encapsulated by a Tf-coated membrane. The
final complex closely resembles a virus particle and is actu-
ally smaller than the sum of the four to eight Tf–liposome par-
ticles that seem to be involved in the formation of these par-
ticles. This is the first indication that each Tf–lipoplex particle
seems to be formed via the condensation of one DNA mole-
cule with several cationic liposomes (Fig. 7).
DISCUSSION
Our results have shown that Tf–lipoplex has (1) a novel
virus-mimicking nanostructure, (2) a uniformly small size of
50–90 nm, (3) a neutral surface charge, (4) a multicenter lamel-
lar core structure with a periodicity of 6–7 nm, and (5) is en-
capsulated by a Tf-coated membrane with Tf molecules pro-
truding as spikes on the surface. These data fit the lamellar LaC
structure model (Radler et al., 1997; Lasic et al., 1997; Koltover
et al., 1998) quite well. Lasic and colleagues (1997) used a com-
bination of cryo-EM and SAXS to examine a lipoplex and found
that the lamellar structure has a periodicity (space between lipid
bilayers) of 6.5 nm, consistent with the dimensions of a bilayer
(4 nm) and a hydrated DNA helix (2.5 nm). Radler and co-
workers (1997) also showed the SAXS pattern of another
lipoplex with a clear periodic structure of 6.5-nm spacing. But
questions arise when comparing our Tf–lipoplex structure with
the reported lipoplex structures, all of which have the lamellar
LaC structure. How would the Tf-coated cationic liposomes ef-
ficiently condense DNA into this virus-mimicking nanostruc-
ture? How are Tf molecules involved in the three-step process
discussed above?
In general, plasmid DNA is a circular molecule of about 900
nm (contour length) in the form of a flexible supercoil (Kennedy
et al., 2000), strongly depending on salt concentration. At nor-
mal low salt concentrations DNA is stiff (persistence length)
relative to the size and flexibility of the liposomes. However,
Lasic et al. (1997) and Templeton et al. (1997) postulate a con-
densation and increased flexibility of DNA on interaction with
cationic lipid. Our Tf–liposomes are 25–30 nm in diameter with
a 2.5-nm Tf coating. The final condensation in step 3 above is
crucial in ensuring formation of the compact, virus-mimicking
nanostructure. DNA-induced vesicle rupture and reorganiza-
tion, as described by Huebner et al. (1999) and Kennedy et al.
(2000), may be involved in this step. Tf plays a critical role in
this process as well, as, consistent with other reports (Gustafs-
son et al., 1995; Templeton et al., 1997; Battersby et al., 1998),
complexing DNA with cationic liposomes without Tf forms
only large lamellar structures of 150–400 nm, with a strong pos-
itive surface charge (z potential, 130–35 mV). In contrast, our
Tf-coated cationic liposomes are apparently able to efficiently
condense DNA into this virus-mimicking nanostructure, with a
size of 50–90 nm and neutral surface charge. We propose that
it is this novel structure that is most likely responsible for the
high efficiency and efficacy of the systemic tumor-targeted gene
delivery.
According to the mathematical models of the lamellar LaC
structure for lipoplex (Dan, 1997; Harries et al., 1998; Koltover
et al., 2000; May et al., 2000), the water gap between lipid bi-
layers (dw) is 2.5 nm and the membrane bilayer thickness (dm)
is 3.5–4.4 nm, depending on the lipid composition. Periodicity
(d) equals dw 1 dm and is 6–7 nm. The space between DNA
strands (dDNA) is 2.5–5.7 nm, depending on the 1:2 charge ra-
tio, and the diameter of a hydrated DNA strand (fDNA) is 2.5
nm. Koltover et al. (2000) described a sharp DNA condensa-
tion transition in an isoelectric lipoplex induced by divalent
electrolyte counterions, leading to a highly condensed lipoplex.
Our cryo-EM shows that Tf–liposomes have a 2.5-nm Tf coat-
ing, corresponding to an apparent diameter of the Tf molecule
(fTf) of 2.5 nm. When Tf–liposomes start to condense DNA
(steps 2 and step 3 above; and see Fig. 7a and b), the mem-
brane-bound 2.5-nm Tf molecule fits into the water gap be-
tween lipid bilayers (dw) and the space between DNA strands
(dDNA). On the basis of our data as well as the lamellar LaC
models mentioned above, and Koltover’s counterion-induced
DNA condensation transition model (Koltover et al., 2000), we
propose a Tf-facilitated DNA-cocondensation model, as illus-
trated in Fig. 7c, for the formation of the Tf–lipoplex particle.
In the three-step process of Tf–lipoplex formation, Tf mole-
cules play a crucial role in facilitating DNA condensation and
lamellar LaC structure formation, possibly by fitting in the space
between lipid bilayers and DNA strands (dw and dDNA) (Fig.
7c), thus changing the anion–cation charge interaction and en-
ergy distribution, similar to Koltover’s bivalent counterion
(Koltover et al., 2000). The presence of Tf in the dw and dDNA
space could balance the complex to isoelectrical status, which
is supported by our observation of the neutral z potential for
the Tf–lipoplex. At this isoelectrical status, in the two dimen-
sions between lipid bilayers, the two lobes of the Tf molecule
(N and C), each of which has one Fe31, might function like a
bivalent counterion by fitting into the major groove of two ad-
jacent parallel DNA helixes (Fig. 7c), leading to reversal, from
repulsive to attractive, of the electrostatic forces (Fe) between
DNA chains. Thus, a DNA condensation transition could oc-
cur, resulting in a highly condensed lamellar core structure
wherein dDNA , fTf 1 fDNA (Fig. 7c). Although in-depth
studies need to be performed to confirm our hypothesis, we pro-
pose that step 3 (described above) may include DNA-induced
vesicle rupture and reorganization (Sternberg et al., 1998;
Huebner et al., 1999) followed by a Tf-induced DNA conden-
sation transition. One speculation on the possible mechanisms
refers to the wrapping of a DNA string around nucleosomes, a
natural process a cell uses to manipulate chromosomal DNA
(P. Frederik, personal communication). The detailed mecha-
nism of interactions among Tf, lipid bilayers, and DNA at the
molecular level still requires more study, and a lamellar to
hexagonal phase (LaC to HIIC) transition (Koltover et al., 1998,
1999) remains a possibility.
The proposed model is further supported by our observation
that reversing the complexing sequence of the three components
for Tf–lipoplex from (Tf 1 liposome) 1 DNA to (liposome 1
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DNA) 1 Tf or (DNA 1 Tf) 1 liposome abolished the unique
nanostructure and transfection efficiency, consistent with an
earlier report (Cheng, 1996). We have also observed that there
are some free Tf molecules present in Tf–liposomes. When we
removed free Tf from Tf–liposomes before complexing DNA,
we were unable to obtain the same nanostructure with the same
size and efficiency (data not shown), indicating that free Tf mol-
ecules are important for the DNA-cocondensation process, even
though we do not yet understand the precise mechanism(s). On
the other hand, free Tf can be removed after Tf–lipoplexes have
formed without changing particle size and biological activity.
This further supports our model in that, during the DNA-in-
duced vesicle rupture and reorganization proposed in step 3 (de-
scribed above), the ruptured or reorganized Tf–liposomes have
inside membranes without Tf coating that are now exposed to
the outside for further DNA condensing. If free Tf is removed,
then, because there is no extra Tf to coat the newly exposed
lipid membranes, the spaces between lipid bilayers and DNA
strands (dw and dDNA) will not be filled and, consequently, will
not be able to balance the anion–cation interaction and energy
distribution. Therefore, there is no electrostatic force reversal
for the DNA condensation transition to occur. Another advan-
tage of the presence of free Tf is that, in step 3 (described
above), the reorganized outermost membrane can be coated
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FIG. 7. Three-step process of Tf–lipoplex particle formation and proposed Tf-facilitated DNA cocondensation model. (a) Rep-
resentative negative-staining EM images of intermediate stages in the Tf–lipoplex formation process. Magnification bar: 100 nm.
(b) Schematic illustration of the three-step process of Tf–lipoplex particle formation. Step 1: Several (four to eight or more)
Tf–liposomes (Tf–Lip) (Tf, in red; Lip, in green) come into contact with a DNA molecule, attaching to the DNA strand (in blue)
by electrostatic interaction. Step 2: The attached Tf–liposomes condense the DNA to form individual lamellar structures along
the DNA strand. Step 3: The individual lamellar structures condense or fuse to form an condensed lamellar core structure, en-
capsulated by a Tf-coated membrane. (c) Illustration of a proposed Tf-facilitated DNA cocondensation model. During step 3, Tf
molecules fit into the dw and dDNA spaces, thus changing the anion–cation charge interaction and energy distribution, balancing
the complex to isoelectrical status. At this status, the Tf molecule might function like a counterion by fitting into the major groove
of two adjacent parallel DNA helixes, leading to reversal from repulsive to attractive electrostatic forces (Fe) between DNA
chains. Thus, a DNA condensation transition could occur, resulting in a highly condensed lamellar core structure wherein dDNA ,
fTf 1 fDNA. The final complex closely resembles a virus particle and is actually smaller than the sum of the four to eight Tf–li-
posomes that seem to be involved in the formation of these particles.
with Tf, which is important for improved stability and also for
tumor targeting through binding to the Tf receptor.
Self-assembly of complex systems consisting of basic or-
ganic components required for life, such as proteins, lipids, nu-
cleotides, as well as inorganic elements, exists widely in nature
(Koltover et al., 2000). However, even in this postgenomic era,
we still know little about the mechanisms behind the self-as-
sembly of these complex biosystems. By learning from nature
we may be able to mimic these natural bioprocesses to develop
better methods for diagnosis, prevention, and treatment of hu-
man diseases. The self-assembly of the Tf–lipoplex nanostruc-
ture system described in this paper consists of protein (Tf),
lipids (cationic liposomes), nucleotides (DNA), and ions
(Fe31); mimicks a virus particle in its architecture and defined
small size; and shows enhanced stability, improved gene trans-
fer efficiency, and efficacy for systemic p53 gene therapy of
human prostate cancer, as well as head and neck cancer, breast
cancer, bladder cancer, and other human tumor models (L. Xu
et al., 1999a, 2001; and L. Xu and E. Chang, unpublished data).
The proposed multistep self-assembly process and protein (Tf)-
facilitated lipid–nucleotide (DNA) cocondensation model could
conceivably exist in the biological world. Somewhat similar
bioprocesses may be used by viruses, bacteria, or eukaryotic
cells, for example, in nucleosome processing of chromosomal
DNA, in mitochondrial DNA, or in hierarchical self-assembly
(Wong et al., 2000). It is also likely that other proteins have a
function similar to Tf. Functionally Tf-like proteins, peptides,
or even polymers (Pitard et al., 1997) could be employed on
the basis of this model to develop functional biosystems. Cur-
rently, we are examining various protein/peptide ligands to de-
velop similar gene delivery systems on the basis of our pro-
posed model. Better understanding and further refinement of
this model may help in the rational design of more efficient and
effective targeted molecular therapeutics for various diseases.
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